1055 West Hastings St, Suite 1700, The Guinness Tower, Vancouver, BC
Year called to bar: 2000 (BC); 2015 (ON)
A partner in the Disputes Group of our Vancouver office, Teresa’s practice focuses on securities litigation and regulation. With more than 20 years of experience, she has worked on multiple shareholder disputes, hostile takeover bids and proxy fights as well as contested plans of arrangement. Teresa’s practice also includes securities class action defence. Teresa’s practice includes securities regulatory matters, where she has represented clients during investigations and enforcement hearings before various provincial securities commissions, which have included allegations of insider trading, illegal distributions, market manipulation, discretionary trading, suitability matters and fraud. She consistently works with registration requirements under securities legislation with respect to trading in securities. She has advised special committees during transactional matters and internal investigations, including whistleblower complaints as well as financial institutions and investment advisors, including in broker-dealer litigation. Prior to joining Osler, Teresa was a partner at a leading regional law firm.
Intrexon Corporation (Intrexon) completed its acquisition of Okanagan Specialty Fruits Inc. (OSF) by way of statutory plan of arrangement pursuant to which a wholly-owned subsidiary of Intrexon acquired all the securities of OSF for US$41 million. OSF shareholders received US$31 million in Intrexon common stock and US$10 million in upfront cash, subject to certain escrow hold-back.
Tekmira Pharmaceuticals Corporation (“Tekmira”) completed a merger of equals with OnCore Biopharma, Inc. (“OnCore”) whereby OnCore merged with a wholly-owned subsidiary of Tekmira. As a result of the merger, stockholders of OnCore hold approximately fifty per cent (50%) of the total number of outstanding shares of capital stock of Tekmira. The implied market value of the combined company, based on the closing price of Tekmira common shares on the NASDAQ Global Market on January 9, 2015, was approximately USD$750 million and at time of closing USD$964 million.
